Dr Charles H Zeigler, DO | |
510 Jamison Ave, Ellwood City, PA 16117-2590 | |
(724) 752-6837 | |
(724) 752-6845 |
Full Name | Dr Charles H Zeigler |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Occupational Medicine |
Location | 510 Jamison Ave, Ellwood City, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114059086 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr Charles H Zeigler, DO 724 Pershing St, Ellwood City, PA 16117-1474 Ph: (724) 752-6837 | Dr Charles H Zeigler, DO 510 Jamison Ave, Ellwood City, PA 16117-2590 Ph: (724) 752-6837 |
News Archive
Researchers in the University of Minnesota's College of Science and Engineering have developed a new noninvasive system that allows people to control a flying robot using only their mind. The study goes far beyond fun and games and has the potential to help people who are paralyzed or have neurodegenerative diseases.
Health care professionals - doctors, hospitals and unionized health care workers - protested planned cuts to California's Medicaid system - Medi-Cal- at the state capitol on Tuesday. They say the governor's proposed budget could shutter a medical center and force doctors to stop taking patients on the program.
The gastric cardiac adenocarcinoma (GCA) is a very rare disease. In recent decades, however, the incidence of the GCA has increased dramatically in many Western countries. An increasing trend in GCA is also observed in municipal regions but not in rural regions of China. Another striking feature is the strong male predominance among patients with GCA. Some of the reasons above are still unclear and require further epidemiological investigations.
Alchemia Limited, today announced the initiation of recruitment for a Phase II clinical study of its lead cancer drug HA-Irinotecan in Small Cell Lung Cancer (SCLC). Two patients have received their first doses of therapy. This investigator sponsored trial is being conducted at Monash Cancer Centre, Southern Health and Peninsula Oncology Centre in Melbourne, Victoria.
› Verified 3 days ago